£158k
+243%vs Mar 2024Active08290141Private limited companyLondon
NEXCAPE PHARMACEUTICALS LTD
Significant control: Samir Haresh Parikh (significant control), Primanex Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Nexcape Pharmaceuticals Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Nexcape Pharmaceuticals Ltd sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NEXCAPE PHARMACEUTICALS LTD is an active private limited company (company number 08290141) incorporated on 12 November 2012, registered in London. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest abridged accounts cover the period ending 31 March 2025, showing net assets of £158k and cash of £129k, with 5 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 243% on the prior period (£46k).
Peer position · net assets
By net assets it sits in the top quarter of 435 comparable companies in London (median £2,000, upper quartile £90k).
02
Ownership and control
- Mr Samir Haresh Parikh
- has significant influence or control
- Primanex Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 November 201213 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 26 November 2026in 33 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
05
Financials
£129k
+2257%vs Mar 2024Not disclosed
5
−17%vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £158k | £129k | £3.02m | — | — | — | 5 |
| 31 March 2024 | £46k | £5,482 | £1.82m | — | — | — | 6 |
Cash per employee£26kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £157,638 at 31 March 2025
- Net assets up 10% or more on the prior period+243.3% vs prior period
- Cash at bank of £50,000 or moreCash £129,188
- Incorporated five or more years agoIncorporated 12 November 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 68 days
- Confirmation statement duein 33 days
- Accounts period endNet assets £158k · abridged accounts
- Accounts period endNet assets £46k · abridged accounts
- Incorporated
08
Similar companies in London
09
Reminders for NEXCAPE PHARMACEUTICALS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.